secwatch.observer — SEC 8-K summary
======================================

Issuer:     GRI Bio, Inc. (GRI)
CIK:        0001824293
Form:       8-K
Filed at:   2024-10-22T23:59:59+00:00
Accession:  0001824293-24-000141
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 3.02, 3.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GRI Bio amends warrants; raises $0.8M by reducing exercise price to $1.00
-------------------------------------------------------------------------

- Entered repricing agreements for 762,236 Series B warrants; holders exercise at $1.00/share (down from $14.30) for gross proceeds of $762,236.
- Issued new Series D-1 (5-year term) and Series D-2 (18-month term) warrants, also exercisable at $1.00/share.
- Net proceeds to be used for working capital and general corporate purposes; offering closed October 22, 2024.
- H.C. Wainwright acted as placement agent, receiving 7% cash fee plus 1% management fee and warrants to purchase 53,357 shares at $1.25.
- New warrants and shares issued in unregistered private placement under Section 4(a)(2) and Regulation D; resale registration to be filed within 30 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1824293/000182429324000141/0001824293-24-000141-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1824293/000182429324000141/val-20241021.htm
  HTML page:      https://secwatch.observer/filing/0001824293-24-000141

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer